The KPNA1 Knockout A-549 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout population for functional studies of KPNA1. This heterogeneous pool of A-549 cells harbors targeted gene disruptions, enabling investigation of bulk loss-of-function effects while minimizing clonal variation. The polyclonal format is suitable for diverse applications, including protein analysis, nuclear transport assays, and pathway interrogation. Users can employ this model to explore KPNA1-dependent mechanisms without the constraints of single-cell isolates.
The A-549 cell line, derived from a lung adenocarcinoma in a 58-year-old male, is a widely used model in cancer biology and respiratory research. These cells exhibit characteristics of human alveolar type II epithelial cells and have been instrumental in studies of oncogene addiction, drug metabolism, and viral pathogenesis. This established host background enables direct evaluation of KPNA1??s role in nucleocytoplasmic transport within a lung cancer context.
KPNA1 encodes importin alpha-1, a key nuclear transport receptor that recognizes classical NLS motifs on cargo proteins. Together with importin beta (KPNB1) and the RanGTPase system, it facilitates translocation through the nuclear pore complex. KPNA1 imports transcription factors such as NF-kappaB, STAT1, and p53, linking it to cell cycle regulation, apoptosis, and immune signaling. Its activity is modulated by upstream factors like CDK1 and nucleoporins NUP50 and NUP153. Disruption of KPNA1 enables systematic dissection of these transport mechanisms.
In A-549 adenocarcinoma cells, loss of KPNA1 can perturb nuclear localization of transcription factors critical for cancer progression. This model is particularly relevant for investigating how altered import affects p53 and NF-kappaB signaling, cell proliferation, and drug sensitivity. Additionally, since KPNA1 facilitates nuclear entry of viral proteins, these cells can be used to study host-pathogen interactions with viruses such as influenza, offering insights into viral pathogenesis and potential therapeutic targets.
Research applications include Western blotting and immunofluorescence for protein level and localization, and subcellular fractionation to assess nucleocytoplasmic distribution. Co-immunoprecipitation can probe KPNA1-cargo interactions, while nuclear import assays using NLS reporters measure transport efficiency. Reporter gene assays monitor transcriptional activity, and cell proliferation/drug sensitivity studies evaluate functional outcomes. These cells are also suitable for viral infection experiments. Contact Ascent Research for further details.
